Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Iteos Therapeutics, Inc. (ITOS)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 37,960,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   iTeos Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of a differentiated immuno-oncology therapeutics for patients. Co.'s product candidate, inupadenant, is designed as a selective small molecule antagonist of the adenosine A2a receptor, in the adenosine pathway, a main driver of immunosuppression in the tumor microenvironment across a range of tumors. Co.'s main antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains, an immune checkpoint with multiple mechanisms of action leading to immunosuppression.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 5,000 5,000
Total Buy Value $0 $0 $41,850 $41,850
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 350,000 379,615
Total Sell Value $0 $0 $5,692,673 $6,289,886
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 3
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 227
  Page 2 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lager Joanne Jenkins Chief Medical Officer   •       –      –    2022-03-11 4 OE $4.30 $15,050 D/D 3,500 3,500     -
   Mcgrath Yvonne Chief Scientific Officer   •       –      –    2022-03-01 4 S $36.76 $367,570 D/D (10,000) 0     -
   Mcgrath Yvonne Chief Scientific Officer   •       –      –    2022-03-01 4 OE $4.24 $42,400 D/D 10,000 10,000     -
   Detheux Michel Chief Executive Officer   •       –      –    2022-02-23 4 AS $34.30 $497,905 D/D (14,500) 34,700     -
   Lager Joanne Jenkins Chief Medical Officer   •       –      –    2022-02-11 4 AS $35.52 $125,459 D/D (3,500) 0     -
   Lager Joanne Jenkins Chief Medical Officer   •       –      –    2022-02-11 4 OE $4.30 $15,050 D/D 3,500 3,500     -
   Detheux Michel Chief Executive Officer   •       –      –    2022-01-25 4 AS $35.45 $517,378 D/D (14,500) 49,200     -
   Lager Joanne Jenkins Chief Medical Officer   •       –      –    2022-01-14 4 AS $39.25 $137,614 D/D (3,500) 0     -
   Lager Joanne Jenkins Chief Medical Officer   •       –      –    2022-01-14 4 OE $4.30 $15,050 D/D 3,500 3,500     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2022-01-05 4 S $42.03 $1,275,484 I/I (30,347) 4,484,728     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2022-01-05 4 S $42.03 $762,214 I/I (18,135) 2,738,785     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2022-01-05 4 S $42.03 $762,214 I/I (18,135) 2,738,785     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2022-01-04 4 S $42.05 $9,176,850 I/I (215,122) 4,515,075     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2022-01-04 4 S $42.05 $5,483,836 I/I (128,550) 2,756,920     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2022-01-04 4 S $42.05 $5,483,836 I/I (128,550) 2,756,920     -
   Davis Aaron I. Director   –       •      –    2022-01-04 4 S $41.84 $7,898,264 D/D (184,677) 0     -
   Davis Aaron I. Director   –       •      –    2022-01-03 4 S $47.63 $24,677,379 D/D (515,323) 46,477     -
   Biniszkiewicz Detlev Director   –       •      –    2022-01-03 4 AS $51.90 $181,650 D/D (3,500) 0     -
   Biniszkiewicz Detlev Director   –       •      –    2022-01-03 4 OE $19.00 $66,500 D/D 3,500 3,500     -
   Lager Joanne Jenkins Chief Medical Officer   •       –      –    2022-01-03 4 AS $51.90 $363,300 D/D (7,000) 0     -
   Lager Joanne Jenkins Chief Medical Officer   •       –      –    2022-01-03 4 OE $4.30 $30,100 D/D 7,000 7,000     -
   Gall Matthew Chief Financial Officer   •       –      –    2021-12-27 4 S $46.45 $232,250 D/D (5,000) 14,429     -
   Detheux Michel Chief Executive Officer   •       –      –    2021-12-22 4 AS $44.31 $727,888 D/D (16,163) 63,700     -
   Detheux Michel Chief Executive Officer   •       –      –    2021-12-22 4 OE $4.30 $7,151 D/D 1,663 79,863     -
   Detheux Michel Chief Executive Officer   •       –      –    2021-12-21 4 AS $44.15 $853,906 D/D (19,226) 78,200     -
  227 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us